OGTT at Home Using CGM vs at the Clinic
Sponsored by Linkoeping University
About this trial
Last updated 2 months ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started a year ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Prediabetes indicated by ≥2 of the following values, measured at separate occasions or through different analyses during the past 2 years:
* - Fasting venous plasma glucose ≥6.1 but ≤6.9 mmol/L
* - Non-fasting venous plasma glucose ≥7.8 but ≤11.0 mmol/L
* - HbA1c ≥39 but ≤47 mmol/mol
* Access to a smart phone which is compatible with the CGM application and has working Bluetooth connectivity
* Ability to read and respond to online instructions and questionnaires in Swedish.
Exclusion Criteria
* T2D indicated by ≥2 of the following values, measured at different occasions or through different analyses:
* - Fasting venous plasma glucose ≥7.0 mmol/L
* - Non-fasting venous plasma glucose value ≥11.1 mmol/L
* - HbA1c ≥48 mmol/mol
* Previous bariatric surgery e.g., gastric by-pass or gastric sleeve surgery
* Body mass index <20 kg/m2
* Body weight <43 kg
* Current pregnancy
* Need of regular use of GLP-1 receptor agonists, SGLT-2 inhibitors, acetaminophen or ascorbic acid supplements during the study period
* Fear of needle sticks
* Shift work during the study period
* Involvement in the study design, data collection, analysis, or participant recruitment.
